Search Results

There are 25920 results for: content related to: Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumab

  1. You have full text access to this OnlineOpen article
    Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo

    British Journal of Dermatology

    Volume 173, Issue 3, September 2015, Pages: 641–650, K.C. Webb, R. Tung, L.S. Winterfield, A.B. Gottlieb, J.M. Eby, S.W. Henning and I.C. Le Poole

    Version of Record online : 25 AUG 2015, DOI: 10.1111/bjd.14016

  2. POSTERS

    Journal of the European Academy of Dermatology and Venereology

    Volume 19, Issue s2, November 2005, Pages: 1–411,

    Version of Record online : 27 SEP 2005, DOI: 10.1111/j.1468-3083.2005.01311.x

  3. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  4. Posters

    Journal of the European Academy of Dermatology and Venereology

    Volume 18, Issue s2, November 2004, Pages: 193–557,

    Version of Record online : 15 OCT 2004, DOI: 10.1111/j.1468-3083.2004.01152.x

  5. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  6. You have free access to this content
    Poster Presentation Abstracts

    International Journal of Rheumatic Diseases

    Volume 19, Issue S2, September 2016, Pages: 21–293,

    Version of Record online : 19 SEP 2016, DOI: 10.1111/1756-185X.12962

  7. You have free access to this content
    Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity

    Arthritis & Rheumatism

    Volume 64, Issue 12, December 2012, Pages: 3850–3855, Charlotte L. Krieckaert, Anna Jamnitski, Michael T. Nurmohamed, Piet J. Kostense, Maarten Boers and Gertjan Wolbink

    Version of Record online : 28 NOV 2012, DOI: 10.1002/art.34680

  8. You have free access to this content
    Interventions for hidradenitis suppurativa

    Intervention Review

    The Cochrane Library

    John R Ingram, Pick-Ngor Woo, Ser Ling Chua, Anthony D Ormerod, Nemesha Desai, Anneke C Kai, Kerry Hood, Tara Burton, Francisco Kerdel, Sarah E Garner and Vincent Piguet

    Published Online : 7 OCT 2015, DOI: 10.1002/14651858.CD010081.pub2

  9. You have free access to this content
    New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases

    Journal of the European Academy of Dermatology and Venereology

    Volume 31, Issue 1, January 2017, Pages: 181–186, L. Méry-Bossard, K. Bagny, G. Chaby, A. Khemis, F. Maccari, H. Marotte, J.L. Perrot, Z. Reguiai, M.L. Sigal, M. Avenel-Audran, T. Boyé, A. Grasland, J. Gillard, D. Jullien and E. Toussirot

    Version of Record online : 13 JUN 2016, DOI: 10.1111/jdv.13759

  10. You have free access to this content
    Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 9, November 2014, Pages: 1044–1055, C. Ma, V. Huang, D. K. Fedorak, K. I. Kroeker, L. A. Dieleman, B. P. Halloran and R. N. Fedorak

    Version of Record online : 3 SEP 2014, DOI: 10.1111/apt.12940

  11. You have free access to this content
    Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 12, June 2010, Pages: 1296–1309, R. PANACCIONE, J.-F. COLOMBEL, W. J. SANDBORN, P. RUTGEERTS, G. R. D’HAENS, A. M. ROBINSON, J. CHAO, P. M. MULANI and P. F. POLLACK

    Version of Record online : 18 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04304.x

  12. You have free access to this content
    Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study

    The Journal of Dermatology

    Volume 37, Issue 4, April 2010, Pages: 299–310, Akihiko ASAHINA, Hidemi NAKAGAWA, Takafumi ETOH, Mamitaro OHTSUKI and THE ADALIMUMAB M04-688 STUDY GROUP

    Version of Record online : 26 FEB 2010, DOI: 10.1111/j.1346-8138.2009.00748.x

  13. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  14. You have free access to this content
    Pharmacokinetics and concentration–effect relationship of adalimumab in rheumatoid arthritis

    British Journal of Clinical Pharmacology

    Volume 79, Issue 2, February 2015, Pages: 286–297, David Ternant, Emilie Ducourau, Piéra Fuzibet, Céline Vignault, Hervé Watier, Thierry Lequerré, Xavier Le Loët, Olivier Vittecoq, Philippe Goupille, Denis Mulleman and Gilles Paintaud

    Version of Record online : 20 JAN 2015, DOI: 10.1111/bcp.12509

  15. You have free access to this content
    Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 9, November 2013, Pages: 1002–1024, G. W. Moran, A. W. K. Lim, J. L. Bailey, M.-F. Dubeau, Y. Leung, S. M. Devlin, K. Novak, G. G. Kaplan, M. Iacucci, C. Seow, L. Martin, R. Panaccione and S. Ghosh

    Version of Record online : 25 SEP 2013, DOI: 10.1111/apt.12491

  16. FREE COMMUNICATIONS

    Journal of the European Academy of Dermatology and Venereology

    Volume 19, Issue s2, November 2005, Pages: 1–58,

    Version of Record online : 27 SEP 2005, DOI: 10.1111/j.1468-3083.2005.01310.x

  17. You have free access to this content
    Bristol Cup Posters

    British Journal of Dermatology

    Volume 173, Issue S1, July 2015, Pages: 21–76,

    Version of Record online : 7 JUL 2015, DOI: 10.1111/bjd.13761

  18. Adalimumab for treating rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Federico Navarro-Sarabia, Rafael Ariza-Ariza, Blanca Hernandez-Cruz and Isidro Villanueva

    Published Online : 20 JUL 2005, DOI: 10.1002/14651858.CD005113.pub2

  19. Tumour necrosis factor-α antagonists as therapies for vitiligo

    British Journal of Dermatology

    Volume 173, Issue 3, September 2015, Page: 635, E.H. Kemp

    Version of Record online : 25 SEP 2015, DOI: 10.1111/bjd.14057

  20. You have free access to this content
    Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn’s disease

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 3, August 2011, Pages: 306–317, M. A. Kamm, S. B. Hanauer, R. Panaccione, J.-F. Colombel, W. J. Sandborn, P. F. Pollack, Q. Zhou and A. M. Robinson

    Version of Record online : 5 JUN 2011, DOI: 10.1111/j.1365-2036.2011.04717.x